HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study.

Abstract
Polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose (poly-ICLC) (10-50 mcg/kg, administered intramuscularly one to three times weekly) was given for < or = 56 months to 38 patients with malignant gliomas. There was minimal or no toxicity. Twenty of 30 patients (66%) receiving at least twice weekly poly-ICLC showed regression or stabilization of gadolinium-enhancing tumor, as revealed by magnetic resonance imaging (median = 65% volume decrease). All but one patient with anaplastic astrocytomas who received continuous poly-ICLC remain alive, with a median progression-free survival of 54 months from diagnosis. Median Kaplan-Meier survival is 19 months for patients with glioblastomas who receive at least twice weekly poly-ICLC treatments. Tumor response was associated with 2',5' -oligoadenylate synthetase activation (P = 0.03) but not with serum interferon. We hypothesize clinical activation by poly-ICLC of a basic host tumor suppressor system. Prolonged, quality survival with tumor stabilization or regression confirmed by magnetic resonance imaging for most patients with anaplastic astrocytomas and glioblastomas suggests that more extensive laboratory and controlled clinical studies are warranted. The concept of long-term, broad spectrum stimulation of host defenses with nontoxic, inexpensive double-stranded ribonucleic acids, such as low-dose poly-ICLC, may be applicable to the treatment of other malignancies.
AuthorsA M Salazar, H B Levy, S Ondra, M Kende, B Scherokman, D Brown, H Mena, N Martin, K Schwab, D Donovan, D Dougherty, M Pulliam, M Ippolito, M Graves, H Brown, A Ommaya
JournalNeurosurgery (Neurosurgery) Vol. 38 Issue 6 Pg. 1096-103; discussion 1103-4 (Jun 1996) ISSN: 0148-396X [Print] United States
PMID8727138 (Publication Type: Journal Article)
Chemical References
  • Interferon Inducers
  • Polylysine
  • Carboxymethylcellulose Sodium
  • Poly I-C
Topics
  • Adult
  • Aged
  • Astrocytoma (mortality, pathology, therapy)
  • Brain Neoplasms (mortality, pathology, therapy)
  • Carboxymethylcellulose Sodium (administration & dosage, adverse effects)
  • Chemotherapy, Adjuvant
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Glioblastoma (mortality, pathology, therapy)
  • Humans
  • Interferon Inducers (administration & dosage, adverse effects)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (pathology, therapy)
  • Pilot Projects
  • Poly I-C (administration & dosage, adverse effects)
  • Polylysine (administration & dosage, adverse effects)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: